See the factory by live video walkthrough
Book an on-site factory visit in Guangzhou
Keratosis Pilaris (KP) affects an estimated 40% of adults, creating persistent rough patches and redness that drive consumers toward targeted body care solutions. For brand owners, the opportunity is clear, but so is the…
Keratosis Pilaris (KP) affects an estimated 40% of adults, creating persistent rough patches and redness that drive consumers toward targeted body care solutions. For brand owners, the opportunity is clear, but so is the regulatory risk: crossing the line into U.S. drug claims can trigger FDA warning letters, market withdrawals, and compromised retailer relationships. This guide outlines formulation pathways and compliant positioning strategies that deliver noticeable results while staying safely within cosmetic boundaries.
Under the Federal Food, Drug, and Cosmetic Act, a product’s intended use determines its classification. A cosmetic is intended to cleanse, beautify, promote attractiveness, or alter the appearance—without affecting the body’s structure or function. A drug, on the other hand, is intended to diagnose, cure, mitigate, treat, or prevent disease, or to affect the structure or function of the body.
In the context of KP, this means terms like “treats keratosis pilaris,” “clears bumps,” or “unclogs follicles” can easily be construed as drug claims by the FDA. Even ingredient-focused claims such as “exfoliates deep within the pore” or “increases cell turnover” can attract scrutiny if they imply a physiological mechanism beyond cosmetic smoothing. The safest path is to formulate from a cosmetic intent and frame all claims around appearance, feel, and sensory benefits.
An effective KP body care product typically relies on a combination of exfoliation, hydration, and barrier support. Below are the primary formulation levers, each designed to deliver visible improvement without invoking drug mechanisms.
Physical exfoliants offer an immediate smoothing effect that aligns naturally with cosmetic positioning. Consider these options:
Claims centered on “polishing,” “smoothing,” and “refining skin’s surface” are defensible cosmetics language for these formats.
Alpha-hydroxy acids (AHAs) and beta-hydroxy acids (BHAs) are staples of KP formulations, but their positioning must be handled with care. The key is to frame them as cosmetic exfoliants that remove dead surface cells, not as agents that alter skin physiology.
Sustained improvement in KP-prone skin often depends on restoring the moisture barrier. Look beyond basic emollients to build a multi-layered hydration system:
Redness is a chief cosmetic concern for KP consumers. Plant-derived active ingredients can be positioned for their calming, cosmetic benefit without making anti-inflammatory drug claims.
The vocabulary you choose is just as important as the formula itself. Below is a side-by-side guide showing language that invites regulatory risk versus language that remains safely within cosmetic territory.
| Risky Wording (Potential Drug Claim) | Safer Cosmetic Alternative |
|---|---|
| Treats keratosis pilaris | Visibly smooths rough, bumpy skin |
| Unclogs follicles / clears bumps | Refines skin texture; gentle polishing action |
| Exfoliates inside the pore | Removes dead surface cells for a softer feel |
| Reduces inflammation | Helps calm the look of red, irritated skin |
| Increases cell turnover | Promotes a brighter, more even-toned appearance |
| Medicated KP therapy | Dermatologist-tested body smoothing treatment |
| Prevents future breakouts | Maintains visibly clearer skin with continued use |
Each alternative focuses on appearance, sensation, or the cosmetic result rather than a physiological mechanism of action. When developing marketing copy, run every claim through this filter: “Does this describe a change in how skin looks or feels, or does it promise to fix an underlying condition?” If it leans toward the latter, revise.
Several tactical decisions can further reduce regulatory exposure while strengthening your product’s market position:
Yes, salicylic acid is permitted in cosmetic formulations, but you must avoid any reference to acne, blemishes, or medicated action. Keep the concentration at 2% or below and position the product as a smoothing or refining body treatment. Any hint of drug intent—such as “fights breakouts” or “clears bumps”—increases FDA risk.
Urea is a widely used cosmetic humectant. The FDA recognizes urea in OTC drug monographs only for specific uses, such as skin protectant claims at certain concentrations. As long as you do not make drug claims (e.g., “removes calluses” or “treats psoriasis”) and use it as a moisturizing or softening agent, urea fits comfortably within cosmetic boundaries.
For body care, lactic acid at 5–10% provides visible exfoliation while remaining gentle enough for most skin types. Rinse-off products can tolerate the higher end of this range; leave-on lotions should start lower, especially for sensitive-skin positioning. Patch testing and formulation pH (ideally 3.5–4.0) are critical to balancing efficacy with tolerability.
Maintain a clean paper trail that demonstrates cosmetic intent from the outset. This includes your product development brief, formulation rationale, claims substantiation documents, and all packaging and marketing drafts. Ensure that every internal communication and supplier specification frames the product as a cosmetic body care item, not a therapeutic solution.
Mentioning the condition itself is not automatically a drug claim, but it elevates scrutiny. If you reference KP, pair it exclusively with cosmetic language: “formulated for skin prone to rough, bumpy patches (commonly called keratosis pilaris)” is safer than “KP treatment.” Always lead with a cosmetic positioning statement and use KP as a contextual descriptor, not as a treatment promise.
Ready to develop a compliant, consumer-loved KP body care product? Our formulation team understands the nuances of U.S. cosmetic regulations and can help you build a product that delivers visible results without the risk. Request a Quote today to begin your custom formulation consultation.
With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.
